X-25013530-GGCCGCGGCGGCCGCGGCCGCGGCT-GGCCGCGGCGGCCGCGGCCGCGGCTGCCGCGGCGGCCGCGGCCGCGGCT

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM4PP5_Very_Strong

The NM_139058.3(ARX):​c.464_465insAGCCGCGGCCGCGGCCGCCGCGGC​(p.Ala148_Ala155dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000246 in 813,857 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.0000096 ( 0 hom., 0 hem., cov: 21)
Exomes 𝑓: 0.0000014 ( 0 hom. 0 hem. )

Consequence

ARX
NM_139058.3 inframe_insertion

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 0.378
Variant links:
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM4
Nonframeshift variant in NON repetitive region in NM_139058.3.
PP5
Variant X-25013530-G-GGCCGCGGCGGCCGCGGCCGCGGCT is Pathogenic according to our data. Variant chrX-25013530-G-GGCCGCGGCGGCCGCGGCCGCGGCT is described in ClinVar as [Pathogenic]. Clinvar id is 96455.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ARXNM_139058.3 linkuse as main transcriptc.464_465insAGCCGCGGCCGCGGCCGCCGCGGC p.Ala148_Ala155dup inframe_insertion 2/5 ENST00000379044.5 NP_620689.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ARXENST00000379044.5 linkuse as main transcriptc.464_465insAGCCGCGGCCGCGGCCGCCGCGGC p.Ala148_Ala155dup inframe_insertion 2/51 NM_139058.3 ENSP00000368332 P1

Frequencies

GnomAD3 genomes
AF:
0.00000955
AC:
1
AN:
104668
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
29916
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000199
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000141
AC:
1
AN:
709189
Hom.:
0
Cov.:
30
AF XY:
0.00
AC XY:
0
AN XY:
214631
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000158
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000955
AC:
1
AN:
104668
Hom.:
0
Cov.:
21
AF XY:
0.00
AC XY:
0
AN XY:
29916
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000199
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Pathogenic, criteria provided, single submitterclinical testingInstitute of Medical Genetics and Applied Genomics, University Hospital TübingenJun 17, 2021- -
Pathogenic, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 08, 2016This variant is the most common pathogenic repeat allele of the second poly-alanine tract (called PA2) within exon 2 of the ARX gene. This repeat allele has been reported with various nomenclatures in multiple individuals with ARX-related diseases including intellectual disability and X-linked infantile spasm syndrome among others.1-4 References: Kato et al. Am J Hum Genet. 2007 Aug;81(2):361-6. Stromme et al. Nat Genet. 2002 Apr;30(4):441-5 Gronskov et al. Eur J Hum Genet. 2004 Sep;12(9):701-5 Marques et al. Mol Genet Genomic Med. 2015 May;3(3):203-14 -
Pathogenic, no assertion criteria providedclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaJan 30, 2015- -
Pathogenic, criteria provided, single submitterclinical testingGeneDxApr 29, 2022Alanine repeat expansion in the second polyalanine tract of the ARX protein, extending the allele to 20 repeats; Published functional studies demonstrate a damaging effect as expansions in the second polyalanine repeat track are suggested to interfere with ARX-related regulation of KDM5C resulting in the misregulation of numerous downstream processes (Poeta et al., 2013); Not observed in unaffected adult males referred for testing at GeneDx; This variant is associated with the following publications: (PMID: 22922607, 11889467, 24528893, 26029707, 24781210, 23246292, 12874418) -
Intellectual disability, X-linked, with or without seizures, arx-related;C3463992:Developmental and epileptic encephalopathy, 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 02, 2024This variant, c.441_464dup, results in the insertion of 8 amino acid(s) of the ARX protein (p.Ala148_Ala155dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the gnomAD database. This variant has been observed in individual(s) with Partington-like syndrome, West syndrome, and/or infantile spasms (PMID: 12874418, 22922607, 24781210, 26029707). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 96455). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on ARX function (PMID: 23246292). This variant results in expansion of a poly-alanine tract in ARX. Expansions of the alanine tracts in ARX have been observed in individuals with ARX-related conditions (PMID: 11889467, 17664401, 23246292). For these reasons, this variant has been classified as Pathogenic. -
X-linked lissencephaly with abnormal genitalia Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoOct 02, 2014- -
Corpus callosum agenesis-abnormal genitalia syndrome;C0796244:Intellectual disability, X-linked, with or without seizures, arx-related;C0796250:Partington syndrome;C1846171:X-linked lissencephaly with abnormal genitalia;C3463992:Developmental and epileptic encephalopathy, 1 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingMolecular Genetics Lab, CHRU Brest-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs398124510; hg19: chrX-25031647; API